Cargando…
DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer
BACKGROUND: Studies have shown that DAB2IP inhibits cancer progression, while HSP90AA1 promotes cancer progression. However, the specific regulatory mechanism of DAB2IP and HSP90AA1 in colorectal cancer (CRC) is not clear. Our aim is to investigate the role and mechanism of DAB2IP and HSP90AA1 in th...
Autores principales: | Zhang, Mengna, Peng, Yanan, Yang, Zhenwei, Zhang, Hailin, Xu, Cong, Liu, Lan, Zhao, Qiu, Wu, Jixiong, Wang, Hongling, Liu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118737/ https://www.ncbi.nlm.nih.gov/pubmed/35590292 http://dx.doi.org/10.1186/s12885-022-09596-z |
Ejemplares similares
-
DAB2IP in cancer
por: Liu, Liang, et al.
Publicado: (2015) -
Soft fibrin matrix downregulates DAB2IP to promote Nanog-dependent growth of colon tumor-repopulating cells
por: Zhang, Meng, et al.
Publicado: (2019) -
Plasma HSP90AA1 Predicts the Risk of Breast Cancer Onset and Distant Metastasis
por: Liu, Haizhou, et al.
Publicado: (2021) -
HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma
por: Xiao, Xin, et al.
Publicado: (2018) -
Looking for adaptive footprints in the HSP90AA1 ovine gene
por: Salces-Ortiz, Judit, et al.
Publicado: (2015)